About this trial
This is a single-centre prospective diagnostic study. When a patient is admitted to the inclusion centre, the clinician responsible for the patient checks the inclusion and exclusion criteria. The no objection from the patient (or their trusted support person or, failing that, a close if the patient is unable to give consent) is sought.The CFS scale is completed and recorded by the clinician in the observation observation notebook.The clinician performs a quadricipital muscle ultrasound, specifically for research purposes, with no changes to the therapeutic and its results are recorded in the observation notebook.
observation notebook.At 3 months after inclusion, information was collected from the medical records to identify secondary endpoints.
Translated with DeepL.com (free version)
Eligibility criteria
Qualifiers
patient aged 65 or over
admitted to intensive care or the outpatient department for less than 24 hours
with an abdominal CT scan less than 30 days prior to admission OR who are scheduled for an scheduled for a routine abdomino-pelvic CT scan within the first 24 hours of admission
Disqualifiers
Neuromuscular disease
Lower limb amputation
Paraplegia > 24 hours before admission
Clearly infected, burnt or lacerated ultrasound site.
Trial design
Treatments tested in this trial
- quadricipital muscle ultrasound